Biodesix, Inc. provided revenue guidance for the year 2022. The company anticipated generating between $37.5 million to $39.5 million in total revenue in 2022.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.595 USD | -0.93% | +3.23% | -13.04% |
May. 21 | Biodesix, Inc. to Present New Data on the Nodify XL2 Test at ATS 2024 Annual Meeting | CI |
May. 13 | TD Cowen Starts Biodesix With Buy Rating, $2.80 Price Target | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.04% | 234M | |
-17.74% | 8.18B | |
+69.46% | 4.32B | |
+5.67% | 2.74B | |
-2.98% | 2.62B | |
-52.71% | 1.95B | |
-19.34% | 1.67B | |
-22.62% | 1.41B | |
+16.51% | 1.2B | |
-45.36% | 1.12B |
- Stock Market
- Equities
- BDSX Stock
- News Biodesix, Inc.
- Biodesix, Inc. Provides Revenue Guidance for the Year 2022